These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 233965)
1. Short communication. "Sombrero" hemolytic plaques due to antibody of a single specificity against pneumococcal polysaccharide. Byfield P Cell Immunol; 1975 Jan; 15(1):222-5. PubMed ID: 233965 [No Abstract] [Full Text] [Related]
2. Regulatory role of T cells in IgG antibody formation and immune memory to type III Pneumococcal polysaccharide. Braley-Mullen H J Immunol; 1974 Dec; 113(6):1909-20. PubMed ID: 4154347 [No Abstract] [Full Text] [Related]
3. Conversion of type III pneumococcal polysaccharide low responders to high responders by immunization with a thymus-dependent form of antigen. Braley-Mullen H; Sharp GC Cell Immunol; 1974 Apr; 12(1):49-60. PubMed ID: 4156496 [No Abstract] [Full Text] [Related]
4. Studies on immunological paralysis. XI. A comparison of the tolerogenicity in vitro of levan and type 3 pneumococcal polysaccharide. Kotlarski I; Courtenay BM; Howard JG Eur J Immunol; 1973 Aug; 3(8):496-502. PubMed ID: 4148233 [No Abstract] [Full Text] [Related]
5. Characteristics of B cell tolerance induced with T-independent polysaccharides. Howard JG; Miranda JJ; Zola H; Christie GH Adv Exp Med Biol; 1973; 29(0):369-75. PubMed ID: 4152808 [No Abstract] [Full Text] [Related]
6. Increased plaque-forming cell response to pneumococcal polysaccharide type 3-coated sheep erythrocytes after priming with erythrocytes but not with polysaccharide. Byfield P Cell Immunol; 1972 Apr; 3(4):616-22. PubMed ID: 4401911 [No Abstract] [Full Text] [Related]
7. Induction of primary and inhibition of secondary antibody response to hapten by hapten conjugates of type III pneumococcal polysaccharide. Lerman SP; Romano TJ; Mond JJ; Heidelberger M; Thorbecke GJ Cell Immunol; 1975 Feb; 15(2):321-35. PubMed ID: 234300 [No Abstract] [Full Text] [Related]
8. Specific inhibition of plaque formation to phosphorylcholine by antibody against antibody. Cosenza H; Köhler H Science; 1972 Jun; 176(4038):1027-9. PubMed ID: 4113485 [TBL] [Abstract][Full Text] [Related]
9. Anti-pneumococcal polysaccharide type 3 hemolytic plaques in mice: cellular response in immunity and immunologic paralysis. Kerman R; Segre D J Immunol; 1970 May; 104(5):1262-6. PubMed ID: 4392712 [No Abstract] [Full Text] [Related]
10. Studies on immunological paralysis. 8. Pneumococcal polysaccharide tolerance and immunity differences between the Biozzi high and low responder lines of mice. Howard JG; Christie GH; Courtenay BM; Biozzi G Eur J Immunol; 1972 Jun; 2(3):269-73. PubMed ID: 4405751 [No Abstract] [Full Text] [Related]
11. Quantitative and qualitative studies on the primary antibody response to pneumococcal polysaccharides at ehe cellular level. Baker PH; Stashak PW J Immunol; 1969 Dec; 103(6):1342-8. PubMed ID: 4391281 [No Abstract] [Full Text] [Related]
12. Immunity and paralysis in mice. Serological and biological properties of two distinct antibodies to type III pneumococcal polysaccharide. Kearney R; Halliday WJ Immunology; 1970 Oct; 19(4):551-60. PubMed ID: 4394462 [TBL] [Abstract][Full Text] [Related]
13. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells. Baker PJ; Stashak PW; Amsbaugh DF; Prescott B Immunology; 1971 Apr; 20(4):481-92. PubMed ID: 4396489 [TBL] [Abstract][Full Text] [Related]
14. Inheritance of an idiotype associated with the immune response of inbred mice to phosphorylcholine. Sher A; Cohn M Eur J Immunol; 1972 Aug; 2(4):319-26. PubMed ID: 4117282 [No Abstract] [Full Text] [Related]
15. Inhibition of secondary anti-hapten responses with the hapten conjugated to type 3 pneumococcal polysaccharide. Mitchell GF; Humphrey JH; Wiliamson AR Eur J Immunol; 1972 Oct; 2(5):460-7. PubMed ID: 4117341 [No Abstract] [Full Text] [Related]
16. Enhancement of the antibody response to type 3 pneumococcal polysaccharide in mice treated with antilymphocyte serum. Baker PJ; Barth RF; Stashak PW; Amsbaugh DF J Immunol; 1970 May; 104(5):1313-5. PubMed ID: 4392713 [No Abstract] [Full Text] [Related]
17. Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. Baker PJ; Stashak PW; Amsbaugh DF; Prescott B Immunology; 1971 Apr; 20(4):469-80. PubMed ID: 4396488 [TBL] [Abstract][Full Text] [Related]
18. Regulation of the antibody response to type 3 pneumococcal polysaccharide. IV. Role of suppressor T cells in the development of low-dose paralysis. Baker PJ; Stashak PW; Amsbaugh DF; Prescott B J Immunol; 1974 Jun; 112(6):2020-7. PubMed ID: 4151107 [No Abstract] [Full Text] [Related]
19. Letter: The basis for conflicting results obtained in studies on the plaque-forming cell response to type III pneumococcal polysaccharide. Baker PJ; Prescott B J Immunol; 1975 Sep; 115(3):891-2. PubMed ID: 239066 [No Abstract] [Full Text] [Related]
20. Requirement for lymphocyte-macrophage interaction in the response of mouse spleen cultures to pneumococcal polysaccharide. Aaskov JG; Halliday WJ Cell Immunol; 1971 Aug; 2(4):335-40. PubMed ID: 4399613 [No Abstract] [Full Text] [Related] [Next] [New Search]